CEREVEL THERAPEUTICS HOLDINGS INC. - COMMON STOCK
42.21
19-April-24 15:59:59
15 minutes delayed
Stocks
+0.07
+0.17%
Today's range
42.00 - 42.23
ISIN
N/A
Source
NASDAQ
-
NetDania - New 12 months Low: CEREVEL THERAPEUTICS HOLDINGS INC. - COMMON STOCK
25 Sep 2023 09:47:11 By NetDania Notify
-
NetDania - New 12 months Low: CEREVEL THERAPEUTICS HOLDINGS INC. - COMMON STOCK
22 Sep 2023 10:00:08 By NetDania Notify
-
NetDania - New 12 months Low: CEREVEL THERAPEUTICS HOLDINGS INC. - COMMON STOCK
21 Sep 2023 12:31:40 By NetDania Notify
-
Cerevel Therapeutics to Present at Morgan Stanley 21st Annual Global Healthcare Conference
29 Aug 2023 06:30:00 By Nasdaq GlobeNewswire
-
NetDania - New 12 months Low: CEREVEL THERAPEUTICS HOLDINGS INC. - COMMON STOCK
07 Aug 2023 09:47:06 By NetDania Notify
-
NetDania - New 12 months Low: CEREVEL THERAPEUTICS HOLDINGS INC. - COMMON STOCK
04 Aug 2023 12:31:47 By NetDania Notify
-
Cerevel Therapeutics Reports Second Quarter 2023 Financial Results and Business Updates
02 Aug 2023 06:30:00 By Nasdaq GlobeNewswire
-
05 Jul 2023 06:30:00 By Nasdaq GlobeNewswire
-
15 Jun 2023 06:30:00 By Nasdaq GlobeNewswire
-
Cerevel Therapeutics Appoints Susan Altschuller, Ph.D. as Chief Financial Officer
10 May 2023 06:30:00 By Nasdaq GlobeNewswire
-
03 May 2023 06:30:00 By Nasdaq GlobeNewswire
-
Cerevel Therapeutics to Present at the BofA Securities 2023 Health Care Conference
26 Apr 2023 06:30:00 By Nasdaq GlobeNewswire
-
11 Apr 2023 06:30:00 By Nasdaq GlobeNewswire
-
Cerevel Therapeutics to Present at the Stifel 2023 CNS Days
21 Mar 2023 06:30:00 By Nasdaq GlobeNewswire
-
Cerevel Therapeutics to Present at the 43rd Annual Cowen Health Care Conference
02 Mar 2023 06:30:00 By Nasdaq GlobeNewswire
-
22 Feb 2023 06:30:00 By Nasdaq GlobeNewswire
-
01 Feb 2023 06:30:00 By Nasdaq GlobeNewswire
-
09 Jan 2023 06:30:00 By Nasdaq GlobeNewswire
-
Cerevel Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
04 Jan 2023 06:30:00 By Nasdaq GlobeNewswire
-
19 Dec 2022 06:30:00 By Nasdaq GlobeNewswire